1. Home
  2. LENZ vs BNR Comparison

LENZ vs BNR Comparison

Compare LENZ & BNR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo LENZ Therapeutics Inc.

LENZ

LENZ Therapeutics Inc.

HOLD

Current Price

$9.97

Market Cap

310.4M

Sector

Health Care

ML Signal

HOLD

Logo Burning Rock Biotech Limited

BNR

Burning Rock Biotech Limited

HOLD

Current Price

$21.20

Market Cap

252.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LENZ
BNR
Founded
2019
2014
Country
United States
China
Employees
N/A
N/A
Industry
Medicinal Chemicals and Botanical Products
Medical Specialities
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
310.4M
252.7M
IPO Year
2021
2019

Fundamental Metrics

Financial Performance
Metric
LENZ
BNR
Price
$9.97
$21.20
Analyst Decision
Strong Buy
Analyst Count
5
0
Target Price
$45.60
N/A
AVG Volume (30 Days)
1.1M
32.9K
Earning Date
05-06-2026
06-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$19,088,000.00
N/A
Revenue This Year
$51.35
$111.65
Revenue Next Year
$198.33
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$8.25
$2.18
52 Week High
$50.19
$41.72

Technical Indicators

Market Signals
Indicator
LENZ
BNR
Relative Strength Index (RSI) 47.63 55.95
Support Level $8.99 $19.72
Resistance Level $10.29 $23.42
Average True Range (ATR) 0.68 1.43
MACD 0.25 0.91
Stochastic Oscillator 87.82 81.30

Price Performance

Historical Comparison
LENZ
BNR

About LENZ LENZ Therapeutics Inc.

LENZ Therapeutics Inc is a late-stage biopharmaceutical company focused on developing and commercializing therapies to improve vision and developing ophthalmic pharmaceutical products. Its products VIZZ (aceclidine ophthalmic solution) 1.44% is a once-daily eye drop developed to restore clear near vision for up to 10 hours. VIZZ is powered by aceclidine, highlighted by its differentiated mechanism of action as a predominantly pupil-selective miotic that interacts with the iris, with minimal ciliary muscle stimulation.

About BNR Burning Rock Biotech Limited

Burning Rock Biotech Ltd is a cancer diagnostics company. It is a NGS-based cancer therapy selection company. Its cancer therapy selection platform is built upon advanced proprietary technologies, comprehensive portfolio of products and a two-pronged market-driven commercial infrastructure addressing both larger hospitals through company's in-hospital model and smaller hospitals through its central laboratory model. It had three operating segments, including Central laboratory business, In-hospital business and Pharma research and development services. It generates the majority of its revenue from Central laboratory business. Its products are Pan-HEME, OncoScreen-WES, brPROPHET, OncoScreen Plus, and others.

Share on Social Networks: